Miltefosine topical

Drug Profile

Miltefosine topical

Alternative Names: TF 002

Latest Information Update: 21 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator JADO Technologies
  • Class Antineoplastics; Antiparasitics; Phospholipids; Quaternary ammonium compounds
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Atopic dermatitis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 21 Sep 2015 No recent reports on development identified - Phase-II for Atopic dermatitis in Germany (Topical)
  • 20 Feb 2008 Efficacy and pharmacodynamic data from a phase II trial in atopic dermatitis released by JADO Technologies
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top